300016 Beilu Pharmaceutical Co., Ltd.
Overview
Beijing Beilu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. The company provides contrast agents, such as gadopentetate meglumine injection, gadobutrol injection, and gadobenate meglumine injection for MRI contrast; and iohexol injection, iopamidol injection, and iodixanol injection for CT contrast, as well as glimepiride and repaglinide tablets and jiuwei zhenxin granules. It also offers gadolinium-based agents, includin
Employees1188
Market Cap$4.6B
Revenue$1.2B
Listed OnShenzhen Stock Exchange
Ticker300016
CEOMr. Xu Wang
HeadquartersBeijing